Measurable weight loss typically begins by weeks 3-4
The trial demonstrated that participants who reached the higher doses (8 mg and 12 mg) achieved the most substantial weight loss (up to 24.2% at 48 weeks)
Retatrutide may require particular caution or may not be suitable for individuals with: A personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) based on findings in rodent studies, this is a precaution shared across the GLP-1 receptor agonist class in EU and UK product information
Problema: al suspender el frmaco, gran parte del peso perdido se recupera : aproximadamente dos tercios del peso perdido se recupera en 1 ao, lo que sugiere tratamiento crnico para mantener beneficios (4, 5)
Despite their considerable benefits, GLP-1 RAs are associated with various adverse reactions (Fig
Find out if you're eligible for Foundayo, and get started on your weight loss journey